Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr₹35 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹1,019 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹1,019 Cr
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr
Mar2021₹35 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹1,019 Cr
1,045.33
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr
137.32
Mar2021 ₹35 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,330.0 Cr 1.5% -3.5% -10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,218.0 Cr 0.6% 3.6% -12.5% Stock Analytics
DIVIS LABORATORIES ₹175,158.0 Cr 1% 9.4% 8% Stock Analytics
CIPLA ₹126,710.0 Cr 0.9% 1.2% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,586.0 Cr 1.7% 1% 1% Stock Analytics
DR REDDYS LABORATORIES ₹103,496.0 Cr -0.5% -4.2% -6.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-3.5%

-10.6%

SENSEX

1.6%

2.1%

2.6%


You may also like the below Video Courses